Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Sweet and Sour: Impact of Early Glycemic Control on Outcomes in Necrotizing Soft-Tissue Infections.

Beauchamp LC, Mostafavifar LG, Evans DC, Gerlach AT.

Surg Infect (Larchmt). 2019 May/Jun;20(4):305-310. doi: 10.1089/sur.2018.182. Epub 2019 Feb 4.

PMID:
30716012
2.

Ablation of tau causes an olfactory deficit in a murine model of Parkinson's disease.

Beauchamp LC, Chan J, Hung LW, Padman BS, Vella LJ, Liu XM, Coleman B, Bush AI, Lazarou M, Hill AF, Jacobson L, Barnham KJ.

Acta Neuropathol Commun. 2018 Jul 5;6(1):57. doi: 10.1186/s40478-018-0560-y.

3.

Auto-Commentary on: "Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells".

de Beauchamp L, Baquero P, Kuntz EM, Gottlieb E, Helgason GV.

Mol Cell Oncol. 2017 Dec 18;5(1):e1403532. doi: 10.1080/23723556.2017.1403532. eCollection 2018.

4.

Hidden sources of grapefruit in beverages: potential interactions with immunosuppressant medications.

Auten AA, Beauchamp LN, Joshua Taylor, Hardinger KL.

Hosp Pharm. 2013 Jun;48(6):489-93. doi: 10.1310/hpj4806-489.

5.

An arrayed RNA interference genome-wide screen identifies candidate genes involved in the MicroRNA 21 biogenesis pathway.

Shum D, Bhinder B, Ramirez CN, Radu C, Calder PA, Beauchamp L, Farazi T, Landthaler M, Tuschi T, Magdaleno S, Djaballah H.

Assay Drug Dev Technol. 2013 Apr;11(3):191-205. doi: 10.1089/adt.2012.477. Epub 2012 Nov 15.

6.

Selection of hyperfunctional siRNAs with improved potency and specificity.

Wang X, Wang X, Varma RK, Beauchamp L, Magdaleno S, Sendera TJ.

Nucleic Acids Res. 2009 Dec;37(22):e152. doi: 10.1093/nar/gkp864.

7.

LNA incorporated siRNAs exhibit lower off-target effects compared to 2'-OMethoxy in cell phenotypic assays and microarray analysis.

Puri N, Wang X, Varma R, Burnett C, Beauchamp L, Batten DM, Young M, Sule V, Latham K, Sendera T, Echeverri C, Sachse C, Magdaleno S.

Nucleic Acids Symp Ser (Oxf). 2008;(52):25-6. doi: 10.1093/nass/nrn013.

PMID:
18776235
8.

Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244).

Eissmann P, Beauchamp L, Wooters J, Tilton JC, Long EO, Watzl C.

Blood. 2005 Jun 15;105(12):4722-9. Epub 2005 Feb 15.

PMID:
15713798
9.

Phosphorylation of ganciclovir phosphonate by cellular GMP kinase determines the stereoselectivity of anti-human cytomegalovirus activity.

Miller WH, Beauchamp LM, Meade E, Reardon JE, Biron KK, Smith AA, Goss CA, Miller RL.

Nucleosides Nucleotides Nucleic Acids. 2000 Jan-Feb;19(1-2):341-56.

PMID:
10772719
10.

The selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Reproduced from Proc. Natl. Acad. Sci. USA 74, 5716-5720 (1977)

Elion GB, Furman PA, Fyfe JA, de Miranda P, Beauchamp L, Schaeffer HJ.

Rev Med Virol. 1999 Jul;9(3):147-52; discussion 152-3. No abstract available.

PMID:
10479776
11.
12.

Metabolism and pharmacokinetics of a double prodrug of ganciclovir in the rat and monkey.

Krasny HC, Beauchamp L, Krenitsky TA, de Miranda P.

Drug Metab Dispos. 1995 Nov;23(11):1242-7.

PMID:
8591725
13.

An enantiospecific synthesis of the human cytomegalovirus antiviral agent [(R)-3-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)-4- hydroxybutyl]phosphonic acid.

Chamberlain SD, Biron KK, Dornsife RE, Averett DR, Beauchamp L, Koszalka GW.

J Med Chem. 1994 Apr 29;37(9):1371-7.

PMID:
8176714
14.

Review of research leading to new anti-herpesvirus agents in clinical development: valaciclovir hydrochloride (256U, the L-valyl ester of acyclovir) and 882C, a specific agent for varicella zoster virus.

Purifoy DJ, Beauchamp LM, de Miranda P, Ertl P, Lacey S, Roberts G, Rahim SG, Darby G, Krenitsky TA, Powell KL.

J Med Virol. 1993;Suppl 1:139-45. Review.

PMID:
8245881
15.

Nucleotide analogue inhibitors of purine nucleoside phosphorylase.

Krenitsky TA, Tuttle JV, Miller WH, Moorman AR, Orr GF, Beauchamp L.

J Biol Chem. 1990 Feb 25;265(6):3066-9.

16.

Effect of acyclic pyrimidines related to 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine on herpesviruses.

Beauchamp LM, Serling BL, Kelsey JE, Biron KK, Collins P, Selway J, Lin JC, Schaeffer HJ.

J Med Chem. 1988 Jan;31(1):144-9.

PMID:
2826784
17.

Modifications on the heterocyclic base of acyclovir: syntheses and antiviral properties.

Beauchamp LM, Dolmatch BL, Schaeffer HJ, Collins P, Bauer DJ, Keller PM, Fyfe JA.

J Med Chem. 1985 Aug;28(8):982-7.

PMID:
2991522
18.

6-Deoxyacyclovir: a xanthine oxidase-activated prodrug of acyclovir.

Krenitsky TA, Hall WW, de Miranda P, Beauchamp LM, Schaeffer HJ, Whiteman PD.

Proc Natl Acad Sci U S A. 1984 May;81(10):3209-13.

19.

Antiviral agents.

Krenitsky TA, Beauchamp L.

Science. 1983 Jun 10;220(4602):1106. No abstract available.

PMID:
6857236
20.

A bicycle ergometer for high altitude investigations.

Kinnear GR, Kerr BA, Fisher V, Beauchamp L, Smerek P.

Can J Appl Sport Sci. 1982 Mar;7(1):55-7.

PMID:
7094195
21.

Enzymatic phosphorylation of acyclic nucleoside analogs and correlations with antiherpetic activities.

Keller PM, Fyfe JA, Beauchamp L, Lubbers CM, Furman PA, Schaeffer HJ, Elion GB.

Biochem Pharmacol. 1981 Nov 15;30(22):3071-7. No abstract available.

PMID:
6279102
22.

9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group.

Schaeffer HJ, Beauchamp L, de Miranda P, Elion GB, Bauer DJ, Collins P.

Nature. 1978 Apr 13;272(5654):583-5.

PMID:
205792
23.

Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine.

Elion GB, Furman PA, Fyfe JA, de Miranda P, Beauchamp L, Schaeffer HJ.

Proc Natl Acad Sci U S A. 1977 Dec;74(12):5716-20.

24.

[Surprises under cover].

Beauchamp L.

Infirm Can. 1971 Mar;13(3):36-8. French. No abstract available.

PMID:
5205810
25.

Cerebrospinal fluid rhinorrhoea and recurrent purulent meningitis.

BEAUCHAMP LE, BENJAMIN B.

Can Med Assoc J. 1951 Oct;65(4):372-5. No abstract available.

26.

Feeding problems in pediatrics.

BEAUCHAMP LE.

Alberta Med Bull. 1951 Aug;16(3):83-5. No abstract available.

PMID:
14868661

Supplemental Content

Loading ...
Support Center